Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for malnourished kids: Peanut-Free food could save more lives

NCT ID NCT06912620

Disease control Sponsor: International Food Policy Research Institute Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two new types of ready-to-use therapeutic foods (RUTFs) for treating severe and moderate acute malnutrition in children aged 6-59 months in Burkina Faso. The new RUTFs are made without peanuts or dairy, which could lower costs and reduce contamination risks. Over 2,200 children were randomly assigned to receive either the standard peanut-dairy RUTF or one of the two alternatives, and researchers tracked recovery and relapse rates for three months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ready-to-use therapeutic foods (RUTFs) - soy-based or soy-maize-sorghum-based alternatives to standard peanut-dairy RUTF
What this could lead to
If successful, these cheaper, locally-sourced RUTFs could effectively treat child wasting and reduce relapse, making treatment more accessible in low-resource settings.
What could go wrong
This is a completed Phase 3 trial, but results are not yet published. The alternative RUTFs may not be as effective as the standard, or may cause unexpected side effects like allergies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

2,269 people

The number who actually took part.

Started

Mar 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 59 months

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 6-59 months * MUAC \< 12.5 cm, or WLZ/WHZ \< -2 * Absence of clinical complications or nutritional edema * Pass the appetite test * Accompanied by caregiver or legal guardian * Caregiver or legal guardian consents to participate Exclusion Criteria: * Acute malnutrition requiring hospitalization (presence of clinical complications, failure to pass the appetite test, or presence of bilateral pitting edema) * Known allergy to any of the ingredients in the RUTF products * Already enrolled in MAM or SAM treatment program * Presence of physical abnormalities that make measurement of anthropometry impossible * Caregiver has intention to move out of the study area within the next 6 months * Children referred from in-patient facilities to continue in ambulatory care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Moderate acute malnutrition are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cachexia protein-energy malnutrition Severe Acute Malnutrition nutritional deficiency disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Moderate acute malnutrition Severe acute malnutrition Wasting

Contacts and locations

Locations

  • Health centers localted in the region of Hauts-Bassins

    Bobo-Dioulasso, Burkina Faso

More trials for these conditions

Other studies related to the condition(s) this trial covers.